From the Desk of Steve Strazza and Alfonso Depablos
The most significant insider purchase on today’s list comes from Wayne P. Rothbaum, director of Iovance Biotherapeutics $IOVA.
Rothbaum declared a $26.5 million IOVA purchase in a Form 4 filing.
Great Point Partners LLC filed a 13G for UroGen Pharma Ltd $URGN revealing an initial stake of 8.51%.
Here’s The Hot List, with data through September 15, 2023:
In another Form 4, director Jonathan Kraft reported a purchase of $507,650 in TKO Group Holdings $TKO.
There was also insider activity in ChargePoint Holdings $CHPT and Victoria’s Secret & Co $VSCO.
In the options market, there was bullish flow in ADT Inc $ADT, Nordic American Tankers Limited $NAT, and Viking Therapeutics Inc $VKTX.
Stay tuned. We’ll be back on Tuesday with more insider activity.
If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.
And please reach out with any questions. We love hearing from you!
All Star Charts Team